Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Kai L Zheng"'
Autor:
Sem A.O.F. Rikken, Willem L. Bor, Abi Selvarajah, Kai L. Zheng, Amy P. Hack, C. Michael Gibson, Christopher B. Granger, Ohad S. Bentur, Barry S. Coller, Arnoud W.J. van ’t Hof, Jurriën M. ten Berg
Publikováno v:
American Heart Journal. 262:75-82
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::277c33e761c3ab3b3528e824b7c0055e
https://doi.org/10.1016/j.ahj.2023.04.009
https://doi.org/10.1016/j.ahj.2023.04.009
Autor:
Errol W. Aarnink, Marina F.M. Huijboom, Willem L. Bor, Moniek Maarse, Kai L. Zheng, Hugo Ten Cate, Jurriën M. Ten Berg, Lucas V.A. Boersma
Publikováno v:
Thrombosis research. 215
Atrial septal defect, persistent foramen ovale and the left atrial appendage are nowadays often percutaneously closed with implantable devices. These interventions may be complicated by thromboembolic events and the perfect post-procedural antithromb
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93888d153a05a8eedb750118fe07a9b4
https://pubmed.ncbi.nlm.nih.gov/35640513
https://pubmed.ncbi.nlm.nih.gov/35640513
Autor:
Ohad S. Bentur, Christopher B. Granger, Barry S. Coller, Jurriën M. ten Berg, Anne H. Tavenier, Arnoud W J van 't Hof, Rita Lobatto, W L Bor, C. Michael Gibson, Sonja Postma, Kai L Zheng
Publikováno v:
Eurointervention, 17(5), 401-410. Europa Digital & Publishing
EuroIntervention
EuroIntervention
Background: Pre-hospital platelet inhibition in patients with ST-segment elevation myocardial infarction (STEMI) may improve outcomes. RUC-4 is a novel, second-generation glycoprotein IIb/IIIa inhibitor designed for first-point-of-medical-contact tre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::289b6090371e03b00c411b03ffc4baf9
https://cris.maastrichtuniversity.nl/en/publications/14ad768a-8f4c-49f1-a9c0-ea409d761b12
https://cris.maastrichtuniversity.nl/en/publications/14ad768a-8f4c-49f1-a9c0-ea409d761b12
